BBC News - Monday, 8 October, 2001
The meeting comes as research commissioned by the charity Voluntary Service Overseas (VSO) shows that 79% of Britons think the government should make sure people in poor countries have more access to drugs for HIV related illnesses.
The research found 87% of people felt it would be better if people living with HIV/Aids in developing countries paid less for medicines than the prices charged in the UK.
It also found that 79% of people wanted the UK Government to take action to reduce drug prices in poor countries.
Strength of feeling
A spokesman for VSO, which works through volunteers in 74 of the world's poorest countries, said: "The strength of feeling took us by surprise.
"The public not only think medicines should be cheaper in developing countries but they also want the government to take action to make sure this happens."
The charity warned that millions of people in the developing world were denied treatment because of the cost of medicines.
The spokesman highlighted the case of the drug fluconazole, which is used to treat an often fatal form of HIV/Aids-related meningitis.
He said: "A month's course costs about ú270 in both Kenya and in the UK, where it is paid for by the NHS.
"This is more than the ú236 the average Kenyan earns in a year and takes this drug completely out of the reach of the vast majority of Kenyans, who have to buy their own medicines.
"In terms of relative salary, this would be as if someone in the UK had to personally pay around ú17,000 every month for this vital medicine."
Blueprint
The charity has drawn up a blueprint called Street Price in an effort to encourage decision-makers to tackle the crisis.
If implemented, the framework would include a database of low prices to promote competition, a global forum for developing countries to negotiate the lowest charges and price caps to keep costs down.
VSO said simple mechanisms, such as different packaging and different colour tablets, could be put in place to make sure cheap drugs sold to poor countries did not flow back illegally into Britain.
VSO chief executive Mark Goldring said: "We urge our government to take a lead in promoting a global framework for low drug prices, in which companies from all countries compete to drive prices down."
011008
BB011007
Copyright © 2001 - BBC. Reproduction of this article (other than one copy for personal reference) must be cleared through the BBC.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.